Lewis Karen

CIK 00018143041 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001814304

Recent Transactions

38 trades

Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-29$29.52/sh−364→ 70,251 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-22$30.43/sh−1,751→ 70,615 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-21+28,508→ 72,366 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-17$29.96/sh−1,241→ 43,858 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-13$28.70/sh−1,599→ 45,099 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-30$65.53/sh−883→ 46,387 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-29$64.14/sh−367→ 47,270 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-23$63.69/sh−4,286→ 47,637 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-22$65.00/sh−1,738→ 51,923 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-17$65.58/sh−3,276→ 53,661 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-16$66.30/sh+24,666→ 24,666 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16$66.81/sh−1,632→ 56,937 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16+16,963→ 58,569 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-01$86.00/sh−5,000→ 41,504 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-01$34.11/sh+5,000→ 46,504 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-06-01−5,000→ 106,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-04-03$75.00/sh−5,000→ 41,430 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-04-03$34.11/sh+5,000→ 46,430 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-04-03−5,000→ 111,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-23$68.76/sh−1,104→ 41,430 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21+6,628→ 43,087 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-02-21+9,402→ 9,402 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21$58.50/sh−553→ 42,534 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-30$52.76/sh−883→ 36,459 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-27$52.77/sh−367→ 37,342 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-23$51.58/sh−2,955→ 37,709 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-20$52.05/sh−1,411→ 40,664 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-12$52.66/sh+30,845→ 30,845 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-12+19,634→ 42,075 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-04-25−7,500→ 0 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-25−1,250→ 22,224 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-28$38.59/sh−434→ 23,474 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-21+24,774→ 24,774 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-21+17,466→ 23,908 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-28+1,250→ 6,250 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-28+5,000→ 5,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-28+30,000→ 30,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-28+7,500→ 7,500 total

Companies

Apellis Pharmaceuticals, Inc.
Chief People Officer
$APLS

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov